Cargando…
Off‐Label, but on‐Evidence? A Review of the Level of Evidence for Pediatric Pharmacotherapy
Many drugs are still prescribed off‐label to the pediatric population. Although off‐label drug use not supported by high level of evidence is potentially harmful, a comprehensive overview of the quality of the evidence pertaining off‐label drug use in children is lacking. The Dutch Pediatric Formula...
Autores principales: | van der Zanden, Tjitske M., Smeets, Nori J.L., de Hoop‐Sommen, Marika, Schwerzel, Michiel F.T., Huang, Hui Jun, Barten, Lieke J.C., van der Heijden, Joyce E.M., Freriksen, Jolien J.M., Horstink, Akira A.L., Holsappel, Inge H.G., Mooij, Miriam G., de Hoog, Matthijs, de Wildt, Saskia N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9828396/ https://www.ncbi.nlm.nih.gov/pubmed/36069288 http://dx.doi.org/10.1002/cpt.2736 |
Ejemplares similares
-
Best Evidence-Based Dosing Recommendations for Dexmedetomidine for Premedication and Procedural Sedation in Pediatrics: Outcome of a Risk-Benefit Analysis By the Dutch Pediatric Formulary
por: Freriksen, Jolien J. M., et al.
Publicado: (2022) -
Physiologically Based Pharmacokinetic (PBPK) Model-Informed Dosing Guidelines for Pediatric Clinical Care: A Pragmatic Approach for a Special Population
por: Freriksen, Jolien J. M., et al.
Publicado: (2022) -
Lamivudine and Emtricitabine Dosing Proposal for Children with HIV and Chronic Kidney Disease, Supported by Physiologically Based Pharmacokinetic Modelling
por: Jacobs, Tom G., et al.
Publicado: (2023) -
Feasibility of a Pragmatic PBPK Modeling Approach: Towards Model-Informed Dosing in Pediatric Clinical Care
por: van der Heijden, Joyce E. M., et al.
Publicado: (2022) -
Chloroquine Dosing Recommendations for Pediatric COVID‐19 Supported by Modeling and Simulation
por: Verscheijden, Laurens F. M., et al.
Publicado: (2020)